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Abstract
Feline idiopathic cystitis (FIC) is the only spontaneous animal model for human interstitial cystitis (IC), as both possess
a distinctive chronical and relapsing character. Underlying pathomechanisms of both diseases are not clearly established
yet. We recently detected increased urine fibronectin levels in FIC cases. The purpose of this study was to gain further
insight into the pathogenesis by assessing interacting partners of fibronectin in urine of FIC affected cats. Several candidate
proteins were identified via immunoprecipitation and mass spectrometry. Considerable changes in FIC conditions
compared to physiological expression of co-purified proteins were detected by Western blot and immunohistochemistry.
Compared to controls, complement C4a and thioredoxin were present in higher levels in urine of FIC patients whereas loss
of signal intensity was detected in FIC affected tissue. Galectin-7 was exclusively detected in urine of FIC cats, pointing to an
important role of this molecule in FIC pathogenesis. Moderate physiological signal intensity of galectin-7 in transitional
epithelium shifted to distinct expression in transitional epithelium under pathophysiological conditions. I-FABP expression
was reduced in urine and urinary bladder tissue of FIC cats. Additionally, transduction molecules of thioredoxin, NF-kB p65
and p38 MAPK, were examined. In FIC affected tissue, colocalization of thioredoxin and NF-kB p65 could be demonstrated
compared to absent coexpression of thioredoxin and p38 MAPK. These considerable changes in expression level and
pattern point to an important role for co-purified proteins of fibronectin and thioredoxin-regulated signal transduction
pathways in FIC pathogenesis. These results could provide a promising starting point for novel therapeutic approaches in
the future.
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Introduction
Feline idiopathic cystitis (FIC), a common disease occurring
in 55–69% of cats with lower urinary tract signs, is the best
spontaneous animal model for human interstitial cystitis (IC),
also known as painful bladder syndrome [1–2]. FIC represents
most of its features such as bladder pain, urgency and nocturia
in the absence of any other identifiable pathology such as
urinary tract infection or bladder carcinoma [1,3]. The
diagnosis of both IC and FIC can only be made by exclusion
of other diseases and confirmed in cystoscopy by characteristic
mucosal lesions and hemorrhages [4–5]. To the patients’
distress, a causative therapy could not be established so far.
Moreover, both diseases are characterized by their chronical
and relapsing character [1,6].
Despite extensive research the etiology of FIC and IC is still
unknown. In veterinary as well as human medicine there is
a consensus that FIC and IC are multifactorial disease
syndromes involving the urinary bladder. FIC is currently
considered a disease syndrome of several and possibly in-
terrelated mechanisms involving local bladder abnormalities,
abnormalities of the nervous and endocrine system as well as
environmental factors as triggers for psychoneuroendocrine
dysfunction [7]. There is also evidence that viruses, especially
feline Calicivirus (FCV), may play a role at least in some cases
of FIC [8]. Regarding human IC different theories for the
underlying pathomechanism were hypothesized among which
were chronic or subclinical infection, autoimmunity, neurogenic
inflammation or bladder urothelial defects affecting bladder
permeability [9–10]. One field of IC research engaged the
protein contents in urine in order to find potential diagnostic
markers and to gain new insight into the pathophysiology of this
disease [11–13]. Recently, we identified two differentially
expressed proteins in disease, trefoil factor 2 and fibronectin
by comparing the protein profiles in urine of healthy and FIC
diseased cats using proteomic approaches [14–15]. Fibronectin,
a widely expressed high-molecular weight glycoprotein, plays an
important role in cell adhesion, migration, growth, differentia-
tion and wound healing and takes part in a wide variety of
interactions with numerous proteins, such as heparin, collagen
and fibrin [16–17]. It is significantly upregulated in urine of cats
with FIC, indicating a more important role of fibrosis in the
pathogenesis of this disease than previously thought [15].
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e51391
The goal of this study was to closely characterize the fibronectin
interaction network in urine and urinary bladder tissue of cats with
FIC with the aim to gain further insight into the pathophysiology
of this disease.
Materials and Methods
Collection and Preparation of Urine of Healthy and FIC
Cats
All samples were collected from privately owned cats
examined at the Clinic of Small Animal Medicine, LMU
Munich, Germany. A total of 46 urine specimens were collected
and processed. This study included two groups: the FIC group
(n = 26) and the healthy control group (n= 20). Inclusion criteria
for the FIC group were clinical lower urinary tract signs, such
as hematuria, stranguria, pollakisuria and periuria and exclusion
of other diseases of the lower urinary tract such as urolithiasis,
bacterial urinary tract infection and structural abnormalities
(anomalies and neoplasia) [15]. To determine eligibility for
inclusion in this study group, abdominal ultrasonography and
abdominal radiographs, urinalysis including determination of the
urine specific gravity, urine dipstick and urine sediment and
aerobic urine culture were performed. Cats were excluded if
they showed any sign for crystalluria, bacteriuria, urolithiasis,
evidence of structural urinary tract abnormality, or if results of
bacterial culture of the urine sample were positive. Only FIC
cases with concurrent obstruction of the urethra were included
in the study. Healthy control cats were evaluated for health care
at the Clinic of Small Animal Medicine. Inclusion criteria for
the healthy group were no clinical signs of urinary tract disease,
no abnormalities on physical examination and an unremarkable
urinalysis, including specific gravity, dipstick and sediment on
the day of inclusion. Any history of prior urinary tract disease
led to exclusion from the healthy control group. All procedures
performed on any of the cats participating in the study were
medically indicated. No experimental animals were involved.
Urine samples were originally collected for purposes of clinical
work-up and used in scientific research with permission from
the Small Animal Clinic of LMU Munich, Munich, Germany.
Owners gave their consent to use the samples.
A total of 26 urine samples from FIC cats and 20 urine samples
from healthy control cats collected by means of cystocentesis (FIC
n=21, controls n= 20) or catheterization (FIC n= 5) were
included. Cats with FIC were sampled within 24 h after the onset
of clinical signs. Immediately after sampling, native urine was
subjected to urine analysis (see below). Subsequently, urine
samples were centrifuged at 2000 rpm at room temperature
(RT) for 5 min) and the protein content of supernatants as well as
sediments was quantified (see below). Finally, supernatants were
divided into aliquots and immediately stored at –80uC until further
processing.
Collection and Preparation of Urinary Bladder Tissue of
Healthy and FIC Cats
Urinary bladders from three cats with obstructive FIC and four
cats with a healthy urinary tract were obtained freshly post
mortem. Cases with FIC were privately owned and presented as
patients at the Clinic of Small Animal Medicine, LMU Munich,
Germany. The reason for euthanasia of the cats was unrelated to
our study. Control cats with healthy urinary tract were euthanized
due to diseases unrelated to our study and without pathologic
alteration of the urinary tract. Owners gave permission for the
clinical samples to be used scientifically. No experimental animals
were involved.
Urinary bladders were extracted in their entirety within 30 min
after euthanasia and sections of various regions were prepared.
Sections were fixed by immersion in Bouin’s solution (Sigma-
Aldrich, Deisenhofen, Germany), dehydrated in a series of
alcohols and subsequently embedded in paraffin (Microm In-
ternational, Walldorf, Germany).
Urinalysis and Protein Quantification
Prior to centrifugation of urine samples, a hand refractometer
was used to determine urine specific gravity. Additionally,
urinalysis was performed by means of the semi-quantitative
urinalysis sticks (Combur-9 Roche Diagnostics, Grenzach-Wyhlen,
Germany) for determination of pH, total protein content as well as
concentration of glucose, ketones, bilirubin, urobilinogen, nitrite
and blood/erythrocytes. After centrifugation of urine samples
(2000 rpm, RT, 5 min) within 30 min after collection, urine
sediments were examined microscopically. Protein content in
urine supernatants of each cat included in the study was
determined by Bradford analysis (Sigma-Aldrich, Deisenhofen,
Germany).
Immunoprecipitation of Protein Complexes in
Representative FIC Diseased Urine
For immunoprecipitation of fibronectin containing protein
complexes, the urine sample (50 mg) of one FIC cat was
incubated with a polyclonal rabbit anti-human fibronectin
antibody (5 mg IgG) (ThermoFisher, Bonn, Germany), which
according to the manufacturer’s declaration also detects feline
fibronectin, in immunoprecipitation buffer (0.05 M Tris, 0.15 M
NaCl, 0.2% NP40; pH 7.4) at RT for 1 h. As negative control,
the same amount of urine was incubated with purified rabbit
serum IgG (5 mg) (Sigma-Aldrich, Deisenhofen, Germany) using
identical conditions to detect any unspecific antibody binding.
Antibody-bound protein complexes were recovered via binding
to protein G-Sepharose beads (GE Healthcare, Freiburg,
Germany) in illustra MicroSpin G-50 Columns (GE Healthcare).
Therefore, 40 ml protein G-Sepharose beads were washed
several times with immunoprecipitation buffer on the columns
and subsequently incubated with the urine-antibody-, respec-
tively urine-serum-IgG mixture at 4uC for 1 h with gentle
agitation. Afterwards, the Sepharose-bound immunoprecipitates
were centrifuged at 0.8 rpm for 2 s followed by several washing
steps with immunoprecipitation buffer. Immune complexes of
both appendages were eluted from beads into 50 ml of Laemmli
buffer (4% SDS, 20% glycerol, 10% 2-mercaptoethanol,
0.004% bromphenol blue, 0.125 M Tris; pH 6.8) by agitation
on a bench top shaker (1400 rpm) for 10 min and subsequent
heating to 70uC for 10 min. After centrifugation, the superna-
tant containing the immunoprecipitated proteins was separated
by SDS-PAGE (8%) and blotted onto polyvinyldifluoride
membranes (PVDF; GE Healthcare, Freiburg, Germany). After
blocking for 1 h in 1% polyvinylpyrrolidone in PBS-T (PVP-T;
PBS containing 0.05% Tween 20) blots were incubated in
a 1:1000 dilution of polyclonal rabbit anti-human fibronectin
antibody (ThermoFisher) overnight at 4uC followed by detection
of binding by a 1:1500 dilution of HRP-conjugated goat anti-
rabbit IgG antibody (Serotec, Du¨sseldorf, Germany) for 1 h at
RT. Proteins were then visualized with enhanced chemilumi-
nescence (ECL) reagent on X-ray films (Euromed; Christiansen,
Planegg, Germany). Remaining supernatant of immunoprecip-
itation was stored at 220uC for further processing.
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Identification of Co-purified Proteins by Liquid-
chromatography Mass Spectrometry/mass Spectrometry
(LC-MS/MS)
Directly prior to LC-MS/MS analysis, immunoprecipitated
proteins were digested in trypsin and resulting peptides were
separated on a reversed phase chromatography column (PepMap,
15 cm675 mm ID, 3 mm/100A pore size, LC Packings) operated
on a nano-HPLC apparatus (Ultimate 3000, Dionex GmbH,
Idstein, Germany). The nano-HPLC was connected to a linear
quadrupole ion trap-Orbitrap (LTQ Orbitrap XL) mass spec-
trometer (ThermoFisher, Bremen, Germany). The mass spec-
trometer was operated in the data-dependent mode to automat-
ically switch between Orbitrap-MS and LTQ-MS/MS
acquisition. Survey full scan MS spectra (from m/z 300 to 1500)
were acquired in the Orbitrap resolution R=60,000 at m/z 400.
Up to ten most intense ions were in parallel selected for
fragmentation on the linear ion trap using collision induced
dissociation at a target value of 100,000 ions and subsequently
dynamically excluded for 30 s. General mass spectrometry settings
were: electrospray voltage, 1.25–1.4 kV; no sheath and auxiliary
gas flow; ion selection threshold for MS/MS, 500 counts;
activation Q-value for MS/MS, 0.25 and activation time for
MS/MS, 30 ms. MS/MS spectra were exported from the
Progenesis software as Mascot Generic file (mgf) and used for
peptide identification using Mascot (Matrix Science, London, UK;
http://www.matrixscience.com), the Uniprot database (http://
www.uniprot.org) restricted to mammalian entries and the
Ensembl cat database (http://www.ensembl.org) in particular. A
protein was considered as identified if the confidence score was
higher than 30 and if the significance threshold was p#0.01. For
quantification, all peptides allocated to a protein were included
and the total cumulative abundance of the protein was calculated
by summing the abundances of all peptides. Multiple interaction
candidates of fibronectin were discovered of which peptide
identifications are listed in table 1.
Verification and Quantification of Co-purified Proteins
SDS-PAGE, western blotting and signal
quantification. For protein separation, SDS-PAGE was per-
formed loading equal amounts of total protein from all urine
supernatants followed by semidry blotting onto PVDF membranes
(GE Healthcare). Unspecific binding was then blocked with 1%
PVP-T for 1 h at RT. Blots were incubated overnight at 4uC with
the according primary antibody. For detection of candidate
proteins, polyclonal rabbit anti-human complement C4-A (C4a)
antibody (Abcam, Berlin, Germany) was used at a working dilution
of 1:500. Rabbit polyclonal antibody against human galectin-7
(Abcam) was used at a dilution of 1:3000. Polyclonal goat anti-
human fatty acid-binding protein 2 (I-FABP) antibody (Abcam)
was used at a dilution of 1:1000 and rabbit polyclonal anti-human
thioredoxin antibody (Abcam) was utilized at a working dilution of
1:400. Polyclonal rabbit anti-human NF-kB antibody against
subunit p65 was purchased from Cell Signaling, (Frankfurt (Main),
Germany) and was used at a dilution of 1:1000. Working dilution
for polyclonal anti-human p38 MAPK antibody (Cell Signaling)
was 1:300. After three washing steps in PBS-T, blots were
incubated in respective horseradish peroxidase-conjugated sec-
ondary antibody for 1 h at RT to detect binding of primary
antibody. As secondary antibodies, goat anti-rabbit IgG (Serotec,
Du¨sseldorf, Germany, dilution 1:5000) or rabbit anti-goat IgG
(Sigma-Aldrich, Deisenhofen, Germany; dilution 1:1000) were
utilized. Negative controls for all Western blot experiments
included omission of the primary antibody as well as incubation
with isotype-matched primary antibody of irrelevant specificity.
After twelve further washing steps in PBS-T, signals were
detected by ECL on a radiographic film (Euromed). Western blots
were imaged on a transmission scanner operated by LAB SCAN
5.0 software and Western blot signals were quantified by means of
densitometry using ImageQuantTL software v2005 (all GE
Healthcare).
Immunofluorescent labelling of target tissue. Urinary
bladder tissue blocks were sectioned and subsequently mounted on
coated slides (Superfrost; Menzel, Braunschweig, Germany). Heat
antigen retrieval was processed at 99uC for 15 min in 0.1 M
EDTA-NaOH buffer (pH 8.0). Tissue sections were blocked with
1% BSA in TBS-T and appropriate serum for 40 min at RT prior
to incubation with primary antibody. Blocking serum was selected
according to the species the secondary antibody was obtained
from. In the case of labelling with multiple antibodies, blocking
steps (ProteinBlock; Dako, Hamburg, Germany) were inserted
between each antibody incubation. Tissue sections were fluores-
cently labelled by incubation with primary antibodies against
fibronectin (monoclonal mouse anti-human fibronectin-antibody,
1:100), C4a (1:50), galectin-7 (1:500), I-FABP (1:200), thioredoxin
(1:100), NF-kB p65 (1:50), p38 MAPK (1:50) (all antibodies from
Table 1. Urine fibronectin co-purified proteins identified by mass spectrometry.
Protein name Accession no.a Peptide countb Confidence scorec Maximum fold changed
Fibronectin ENSFCAP00000008544 11 575 10.81
Ig kappa chain V region 3315 P01683 2 76 50166.98
Ig gamma chain C region P01870 1 1489 6.25
Alpha-S1-casein P02662 2 82 13.03
Caspase-14 P31944 1 51 7.44
Complement C4-A P0C0L4 2 78 10.14
Galectin-7 P47929 2 104 23.95
Fatty acid-binding protein, intestinal P12104 1 63 14.87
Thioredoxin P10599 1 62 14.98
Multiple co-purified proteins of fibronectin could be identified in urine of FIC cases by LC-MS/MS of which eight are listed. a) Accession number as listed on Uniprot
(http://www.uniprot.org) or Ensembl (http://www.ensembl.org) databases, b) Number of peptides the protein was identified with, c) Confidence score as given in
Mascot were considered as significant if the value was higher than 30 (*p#0.01), d) Ratio of control IP and FIC IP cumulated peptide intensity signal strengths
(progenesis values).
doi:10.1371/journal.pone.0051391.t001
Fibronectin Interactors in Urine of Cats
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e51391
Abcam) and mouse anti-human CD117 (1:50; Serotec); at 4uC
overnight followed by incubation with the respective secondary
antibody for 30 min at RT. Secondary antibodies were Alexa
Fluor dye-labelled and purchased from Invitrogen (Karlsruhe,
Germany). All antibodies were used at a working dilution of 1:500
(goat anti-rabbit IgG Alexa 647, donkey anti-goat IgG Alexa 546
and goat anti-mouse IgG Alexa 488). Isotype controls were
included as negative controls in all immunohistochemical stain-
ings. Cell nuclei were stained with 496-diamidino-2-phenylindol
(Invitrogen; dilution 1:1000). Finally, sections were mounted using
fluorescence mounting medium. Fluorescent images were re-
corded with the Axio Imager M1 (Zeiss, Go¨ttingen, Germany) and
examined with Axio Vision 4.6 software (Zeiss).
Statistical analysis. Calculation of statistical significance
was performed using the Paleontological Statistics (PAST) software
(http://folk.uio.no/ohammer/past/index.html). Variance of pro-
tein expression quantified by means of densitometry using the
ImageQuantTL software was analysed by a Kolmogorov-Smirnov
test. Since the data were not distributed normally, the Mann-
Whitney test was used to calculate statistical significance. The
differences in the protein expression were considered as significant
if the p-value was #0.05.
Results
Novel Potential Interacting Partners of Fibronectin
Identified
For identification of the proteins that coprecipitated with
fibronectin in the immunoprecipitation assay, LC-MS/MS anal-
ysis was used. Multiple co-purified proteins could be clearly
identified as well as fibronectin itself, emphasising the affinity of
the used antibody actually directed against a human target protein
to the feline one (table 1). Peptides with a maximum fold change of
more than 5.5 are listed in table 1. These identified proteins were
Ig kappa chain region V 3315, Ig gamma chain C region, alpha-
S1-casein, caspase-14, C4a, galectin-7, I-FABP and thioredoxin.
Next, we decided to verify changed expression patterns of the
latter four candidates in urine of a cohort of healthy and FIC cases.
Expression of Candidates in Urine of FIC Diseased Cases
and Healthy Controls
Complement C4a and galectin-7 levels are increased in
urine of FIC cases. Quantification of C4a signal intensities in
urine of FIC cases compared to healthy controls showed
a significant (p#0.001) increase of C4a levels in the majority of
tested urine samples of FIC cases (Fig. 1A, black column) with an
almost 5-fold higher concentration in FIC urines compared to
healthy control urines (Fig. 1A, white column).
In urine of FIC cases, (Fig. 1B, black column) we found an
extraordinary upregulation of galectin-7 with a 45-fold higher
expression in urine of FIC compared to healthy control urine
(Fig. 1B, white column) with a p-value of#0.05. Interestingly, only
some urine samples of FIC affected cases revealed a higher
expression, whereas the signal intensity of galectin-7 in some FIC
and all healthy cases was negative (Fig. 1B).
I-FABP level is decreased in urine of FIC cases. Fatty
acid-binding protein 2 (I-FABP), belongs to the fatty acid-binding
protein family and is generally expressed in the entirety of the
intestine [18]. I-FABP is physiologically expressed in urine of
healthy cats as well (Fig. 1C, white column). In contrast, we found
a significant decrease of I-FABP levels to only one half of the
physiological amount in urine of FIC diseased cases, indicating
a loss of I-FABP in FIC (Fig. 1C, black column).
Thioredoxin and the signal transduction molecules NF-kB
p65 and p38 MAPK are upregulated in FIC diseased
urine. Thioredoxin is a small redox-regulating protein that
belongs to the thioredoxin family and plays a role in a wide variety
of biological functions e.g. in oxidative stress [19]. We quantified
the signal intensity of thioredoxin in urine of healthy (Fig. 1D,
white column) and FIC diseased cases (Fig. 1D, black column). An
average increase by a factor of 7.5 in the majority of FIC samples
compared to healthy control samples could be observed. Since
thioredoxin was significantly upregulated in urine of FIC affected
cases, we next were interested which signal transduction pathways
were changed in disease. Therefore, we examined the downstream
molecules NF-kB p65 (NF-kB pathway) and p38 MAPK (MAPK
pathway) [20–21]. Interestingly, we found a 5-fold increased
concentration of NF-kB p65 in almost every urine sample of FIC
affected cases (Fig. 1E, black column) compared to healthy control
urines (Fig. 1E, white column). Moreover, quantification of p38
MAPK expression showed an average upregulation by factor 6.5
in FIC urine (Fig. 1F, black column) in contrast to physiological
p38 MAPK concentration in healthy control urine (Fig. 1F, white
column).
Expression of Fibronectin and its Potential Interacting
Partners in Target Tissue of FIC Cases and Healthy
Controls
To examine the physiological expression of identified co-
purified proteins of fibronectin, we investigated candidate expres-
sion patterns with immunohistochemical methods (Fig. 2A, H&E
staining, Fig. 3, fluorescent double staining and Fig. 4, left panel).
Then, we analyzed appearance of protein partners under FIC
condition (Fig. 2B, H&E staining, Fig. 4 right panel). Represen-
tative staining of FIC affected bladder tissue with H&E showed
marked destruction of normal bladder wall physiology (Fig. 2A)
compared to the characteristic architecture of healthy bladder
tissue (Fig. 2B).
I-FABP and thioredoxin co-localize with the interstitial
cell marker CD117 in the lamina propria mucosae. In
order to define the specific localization of all candidates under
normal condition and to demonstrate the association to certain
structures of the bladder tissue (Fig. 3A), we performed immuno-
histochemical double staining of co-purified proteins with in-
terstitial cell marker CD117, which was markedly expressed in the
umbrella and epithelial cells of the transitional cell epithelium as
well as in the interstitial cells of the lamina propria mucosae
(Fig. 3B). C4a and CD117 overlay could be observed in the
urothelial cells as well as a scattered expression in the interstitial
cells of the subepithelial layer (Fig. 3C). Galectin-7 only showed an
overlay with CD117 in the umbrella cells of the transitional cell
epithelium of the healthy bladder and co-localized in the urothelial
cells (Fig. 3D). Besides a clear overlay of I-FABP and CD117 in the
transitional cell epithelium, an additional co-localization in the
interstitial cells of the lamina propria and a separate expression of
I-FABP extracellularly could be seen (Fig. 3E). Thioredoxin
expression overlapped with CD117 in the epithelial cells of the
urothel as well as in the interstitial cells of the lamina propria
(Fig. 3F).
C4a expression decreases whereas galectin-7 shows
a distinct increase of signal intensity in the transitional
cell epithelium of FIC cases. In comparison to physiological
fibronectin expression in healthy bladder tissues (Fig. 4A) and loss
of fibronectin in FIC diseased tissues (Fig. 4B), C4a was primarily
associated to the apical transitional cell epithelium in physiological
condition (Fig. 4C), whereas, similar to fibronectin, an absence of
C4a expression from bladders of FIC cases was detected (Fig. 4D).
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Figure 1. Quantification of signal intensities of co-purified candidate proteins of healthy and FIC diseased cases. Western blot signal
intensity of healthy controls (white columns, left, n = 20) and diseased urine samples (grey columns, right, n = 16) were compared for the following co-
purified proteins: Complement component 4a (C4a) (A), galectin-7 (B), fatty acid-binding protein, intestinal (I-FABP) (C), thioredoxin (D), NF-kB p65 (E)
and p38 MAPK (F). The according Western blot strips visualize the quantitative difference of signal intensities. The left strips show representative
control blots, the right ones blots with FIC urine. The corresponding band sizes are displayed in black boxes. Signals were quantified by densitometry
and statistical significance was calculated using the Mann-Whitney test. Data are represented in a column bar graph as means with SEM. Expression
level of C4a (A) shows a significant (***p#0.001) increase in urine of FIC diseased cases with an almost 5-fold higher concentration compared to urine
of healthy controls. Galectin-7 (B) is significantly (*p#0.05) upregulated in FIC diseased samples compared to healthy control samples with a 45-fold
higher expression in FIC affected cases. Quantification of I-FABP expression (C) results in a significant (*p#0.05) decrease in urine of FIC cases
compared to urine of healthy controls. Thioredoxin (D) is significantly (***p#0.001) increased by a factor of 7.5 in FIC compared to urine of controls.
Fibronectin Interactors in Urine of Cats
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Galectin-7 showed a considerable change in the expression of
healthy bladder tissues (Fig. 4E) compared to FIC affected tissues
(Fig. 4F): a slight signal intensity in the transitional cell epithelium
and around blood vessels in the subepithelial tunic of healthy
urinary bladders (Fig. 4E), with an obvious increase of galectin-7
expression in FIC diseased bladder tissues in the cytoplasm of cells
of the transitional epithelium (Fig. 4F).
I-FABP and thioredoxin are both expressed in the urinary
bladder tissue of healthy controls whereas thioredoxin
shows a distinct loss of signal intensity in FIC diseased
bladders. I-FABP was expressed throughout all layers of
healthy urinary bladder tissues with a clear reactivity in the
transitional cell epithelium (Fig. 4G). In FIC affected tissues
(Fig. 4H), loss of signal intensity was visible in all tunices of the
urinary bladders.
Thioredoxin was detected in even amounts in all tunices of
healthy bladders (Fig. 4I). In FIC cases (Fig. 4J), all tunices of the
urinary bladders showed a decrease of reactivity of thioredoxin
with a marked leakage into the bladder lumen.
Fibronectin and its interactor thioredoxin are colocalized
in the subepithelial and muscular tunices of healthy
bladder tissues. A coexpression for fibronectin and thiore-
doxin could be demonstrated in the lamina propria mucosae and
the muscle tunic in healthy urinary bladders (Fig. 5A). Addition-
ally, fibronectin was mainly present in the extracellular matrix
(ECM), whereas thioredoxin could be found in the cytoplasm of
cells. We also observed a distinct leakage of signal intensity of both
molecules in all layers of FIC diseased tissues (Fig. 5B) with a loss
of coexpression in the subepithelial and muscular tunices.
NF-kB p65 and p38 MAPK clearly appear in FIC affected
tissues. Quantification of Western blot analyses showed a dis-
tinct upregulation of thioredoxin as well as the signal transduction
molecules NF-kB p65 and p38 MAPK in urine of FIC cases
(Fig. 1E and 1F). We performed immunohistochemical double
labelling of thioredoxin and either NF-kB p65 or p38 MAPK to
investigate the connection between thioredoxin and related signal
transduction cascades in urinary bladder tissues of healthy and
diseased cases. Although thioredoxin was expressed in all tunices
of the healthy urinary bladders (Fig. 5C), NF-kB p65 was not
detectable in any layer of healthy bladder. Interestingly,
thioredoxin was almost absent in FIC diseased sections (Fig. 5D)
except for a weak signal in the transitional cell epithelium and the
lamina propria of the bladder tissues. In contrast, NF-kB p65 was
clearly expressed in the subepithelial tunic of FIC bladders.
Interestingly, a focal colocalization of NF-kB p65 and thioredoxin
could be seen in the lamina propria of FIC diseased bladder tissues
at NF-kB p65 expression sites. P38 MAPK showed a slight
expression in healthy bladder tissues in the transitional cell
epithelium and the lamina propria mucosae (Fig. 5E). In FIC
affected tissues, p38 MAPK was clearly expressed in the cytoplasm
of the umbrella cells of the transitional cell epithelium as well as in
a scattered pattern around cell nuclei in the subepithelial and
muscular tunices, without a co-localization (Fig. 5F).
Discussion
IC/painful bladder syndrome is a common human disease with
a burdensome character that leads to an adverse impact on quality
of life for affected people [22]. The only spontaneous animal
model for IC in humans is currently the feline type of urinary tract
disorder. Besides similarities in the clinical appearance and the
spontaneous occurrence of both diseases, there are many
comparable pathological alterations that indicate the high trans-
ferability and relevant input of FIC and IC research [23].
Regarding this, we focussed our study on the protein interaction
network of fibronectin in FIC diseased cases to elucidate possible
pathomechanisms in the development of this disorder.
To identify potential interacting partners of fibronectin in
diseased urine, we performed co-immunoprecipitation followed by
mass spectrometry analysis. This approach was successful and
numerous co-purified proteins of fibronectin could be discovered
(Table 1). We closely examined four candidates of the co-purified
proteins and verified their expression patterns in urine of a cohort
of healthy and FIC cases (Fig. 1). Furthermore, we investigated
Abundances of NF-kB p65 (E) significantly (***p#0.001) increase in diseased specimens compared to healthy specimens with a 5-fold higher
expression just as p38 MAPK (F) showing an 6.5-fold higher expression (*p#0.05) in FIC diseased urines in comparison to healthy control urines.
doi:10.1371/journal.pone.0051391.g001
Figure 2. H&E staining of normal feline bladder (A) and FIC diseased bladder (B). Histological sections stained with Haematoxylin and
Eosin. Healthy urinary bladder section (A) shows characteristic architecture compared with FIC diseased bladder tissue (B), where a loss of normal
bladder wall physiology can be seen. Notice the marked loss of transitional cell epithelium, the intramucosal bleeding and oedema in the FIC section
(B). a = Transitional cell epithelium, b = Lamina propria mucosae, c = Loss of transitional cell epithelium, d = Intramucosal bleeding and oedema.
doi:10.1371/journal.pone.0051391.g002
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their physiological expression and specific localization in relation
to interstitial cell markers in healthy bladder tissues and their
expression patterns under FIC condition with immunohistochem-
ical methods (Fig. 3 and 4).
A candidate closely examined was C4a, a member of the
complement cascade [24]. Several studies previously investigated
the involvement of complement in the pathogenesis of human IC
[25–27]. A significant depletion of C4 in serum of IC patients
could be found suggesting an involvement of a chronic local
immunological process in the pathogenesis of this disease [25].
Higher amounts of urinary C4a in FIC cases could be the result of
a significant increase of serum levels in FIC. However, fibronectin
Figure 3. Expression of co-purified proteins in healthy bladder tissue. Immunohistochemical double labelling of CD117 and co-purified
proteins in a representative healthy bladder tissue. DIC image of healthy bladder tissue (A). CD117 (green) shows a marked reactivity in the epithelial
cells of the urothel and in the interstitial cells of the lamina propria of the healthy bladder (B). Overlay image of C4a (red) and CD117 (green) reveals
considerable co-localization (overlapping results in yellow colour) at the cell nuclei of the urothelial cells and a scattered expression in the interstitial
cells of the lamina propria (C). Galectin-7 (red) and CD117 (green) show a co-localization in the umbrella cells (marked with an asterisk) of the
transitional cell epithelium, whereas reactivity of both proteins in the epithelial cells of the urothel indicate a co-expression. Cells of the lamina
propria are only CD117 positive (D). I-FABP (red) and CD117 (green) overlay is visible only in the interstitial cells of the lamina propria. Additionally, I-
FABP reactivity is seen extracellularly and is distinctly expressed in the basal membrane (E). Thioredoxin (red) and CD117 (green) co-localize distinctly
at all cell nuclei of the transitional epithelial cells and in the interstitial cells of the subepithelial tunic (F). The blue colour reveals staining of cell nuclei
(DAPI). a = Transitional cell epithelium, b = Lamina propria mucosae, c = Inserted box shows magnification of respective cells in the lamina propria
mucosae.
doi:10.1371/journal.pone.0051391.g003
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was recently reported to be increased in the urine of FIC cats due
to leakage from damaged urinary bladder tissue [15]. Therefore,
the observed decreased abundance of C4a in FIC affected bladder
tissue (Fig. 4C and D), but increased abundance in urine of
diseased cases (Fig. 1A) could both be resulting from cell death and
tissue damage. Helin et al. elucidated the impact of complement to
the development of tissue injury and the chronic self-perpetuating
inflammation typical for IC [27]. Under physiological conditions
complement activation is well-controlled, whereas pathological
alteration accelerates its activation due to stimuli such as tissue
injury [28]. For this reason, we presume that in the case of FIC,
tissue damage of affected bladders cause an augmented activation
of the complement system and an increased abundance of peptide
mediators like C4a in the inflammatory process, which in return
leak into the urine through the damaged, hyper-permeable urinary
bladder wall. Furthermore, intense C4a activation could generate
a more excessive inflammatory response than necessary to
eliminate underlying damage and therefore play a role in the
chronic and relapsing character of the disease.
A very interesting co-purified protein of fibronectin identified in
this study is galectin-7, which was only present in urine of FIC
cases but not in control urine (Fig. 1B). Galectin-7 is mainly
distributed in stratified squamous epithelium in various tissues and
its functions include cell-to-cell adhesion, cell-matrix interaction,
growth regulation and apoptosis [29]. In this study, a physiological
presence of galectin-7 in the transitional epithelium and around
blood vessels in the subepithelial tunic could be demonstrated in
healthy bladder tissues where it co-localizes with CD117, a protein
expressed by interstitial cells of Cajal in the transitional cell
epithelium of the lower urinary tract (Fig. 3D and 4E) [30].
Interestingly, FIC diseased bladder tissues showed an increase of
galectin-7 signal intensity in the transitional epithelium (Fig. 4F).
Galectin-7 plays a crucial role in reepithelialisation of corneal [31],
epidermal wounds [32] and in wound repair of polarized kidney
cells [33]. An increased abundance in the transitional cell
epithelium of FIC diseased bladders indicates an upregulation of
this protein due to loss of physiological structure of the bladder
[15]. We believe that galectin-7 plays an important role in wound
healing and reepithelialisation of the impaired tissue in FIC cases
as well. Furthermore, the extent of acceleration of the reepithe-
lialisation of galectin-7 in corneal wounds was greater than that of
growth factors [31]. Moreover, the clinical potential of galectin-7
seems to be more attractive than that of growth factors due to
absent cell mitosis in epithelial cells [34]. On this account,
galectin-7 could be of greatest interest for developing novel
therapeutic strategies for treatment of FIC and thus also IC.
Fibrosis has recently been proposed to play an important role in
the pathogenesis of FIC [15]. Furthermore, the primary cause of
fibrotic disease has been suggested to be an uncontrolled
Figure 4. Expression pattern of fibronectin and its co-purified
proteins in healthy and diseased bladder tissue. Urinary bladder
expression of fibronectin (green) and its co-purified proteins (red) in
a representative healthy (left panels) and FIC diseased bladder (right
panels). Physiological distribution of fibronectin (green) in healthy
bladder (A). Extracellular matrix of the lamina propria mucosae and the
muscle tunic show a distinct immunoreactivity for fibronectin, whereas
a loss in FIC affected bladder tissue (B), especially in the subepithelial
and muscular tunices, is evident. C4a (red) is moderately expressed in
the apical transitional cell epithelium of the physiological bladder (C)
and disappears in the FIC affected bladder tissue (D). Galectin-7 (red) is
expressed especially in umbrella cells of the transitional epithelium and
around blood vessels in the lamina propria under normal condition (E).
In contrast, expression changes profoundly in FIC affected bladders to
distinct expression in the transitional cell epithelium (F). Reactivity of I-
FABP (red) throughout all tunices in healthy bladder (G) almost
disappears in FIC diseased tissue (H). Thioredoxin (red) reveals
a predominant signal in the entire healthy bladder tissue (I) compared
to a leakage of thioredoxin into the lumen (arrow) of FIC affected
bladder tissue resulting in a slight immunoreactivity of the diseased
bladder tissue (J). The blue colour reveals staining of cell nuclei (DAPI).
a = Transitional cell epithelium, b = Lamina propria mucosae, c =Muscle
tunic, d =Normal vessel.
doi:10.1371/journal.pone.0051391.g004
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differentiation of fibroblasts into myofibroblasts [35]. A novel
study investigated the impact of galectins on the formation of the
ECM demonstrating a galectin-7 dependent stimulation of
myofibroblast formation and a marked production of a three-
dimensional network of fibers containing fibronectin [36]. These
findings provide an interesting insight into the pathogenesis of
disorders engraved by their fibrotic character such as FIC and is
consistent with the findings of our study. In this context, galectin-7
could serve as a positive regulator of tissue fibrosis preventing
uncontrolled ECM formation as a result of chronically relapsing
inflammation in FIC affected tissue.
A further protein that we identified as a possible binding partner
of fibronectin is I-FABP. Several studies described the beneficial
use of I-FABP as a urinary marker for intestinal injuries such as
during or after acute ischemic diseases [37–38] as well as urothelial
carcinomas of the upper urinary tract [39]. We found a reduction
of I-FABP in urine of FIC diseased cases by 50% compared to the
physiological amount in healthy (Fig. 1C). We furthermore
demonstrated a high abundance of I-FABP in all layers of the
bladders, especially in the transitional epithelium (Fig. 4G) and
a lack of I-FABP in FIC tissues (Fig. 4H) as well as a correlation of
I-FABP to interstitial cells of the lamina propria (Fig. 3E). A loss of
I-FABP in transitional epithelium of diseased tissues might be the
result of an absence of cellular tissue. However, I-FABP
concentration was also decreased in urine of FIC cases. In-
terestingly, Hallde´n et al. reported that I-FABP expression in
intestinal epithelial cells is regulated by factors present in the
extracellular matrix such as fibronectin [40]. The decreased
concentration of fibronectin in the bladder tissue due to an
increased bladder permeability [15] could thus be the trigger for
downregulation of I-FABP expression. Since the exact pathways
are still unclear, further studies are necessary to elucidate I-FABP
function in urinary bladder tissue as well.
Another candidate protein identified by mass spectrometry that
seems to be of great significance is thioredoxin. Thioredoxin is
important for many biological functions, such as defense against
oxidative stress and regulation of apoptosis [41]. In this study,
a significantly higher concentration of thioredoxin in urine of FIC
affected cats compared to urine of healthy controls could be
demonstrated (Fig. 1D). We also verified thioredoxin expression in
the transitional cell epithelium, especially in umbrella cells, of
healthy urinary bladder tissue (Fig. 3F). Increased abundance of
thioredoxin in response to oxidative stress and a protective role of
thioredoxin were already reported in renal ischemia/reperfusion
injury inducing secretion of thioredoxin into the urine [42]. The
authors suggested an excretion that is not due to leakage from
dead cells since total protein levels were unchanged in the urine
after reperfusion [42]. Thus, higher amounts of thioredoxin in
urine of FIC cases could be caused by hypoxia in the kidneys as
a result of obstruction of the lower urinary tract. However, distinct
immunohistochemical staining of thioredoxin in control tissues
(Fig. 4I) and a loss of signal intensity in all tunices of diseased
bladders (Fig. 4J) argue against this hypothesis. Thioredoxin was
shown to be over-expressed in bladders of urinary outlet
obstructed rats [43]. Furthermore, a recent study experimentally
induced IC in rats subsequent to exposure to oxidative stress using
bladder instillation of a nitric oxide donor gel [44]. We therefore
assume that the urinary bladder of FIC diseased cases is subject to
apoptosis. As a consequence, injured tissue cells could secrete
cytoplasmic thioredoxin into the urine where it operates as
protector against oxidative stress. In accordance to previous
reports, these findings are suggesting a protective role of
extracellularly injected recombinant human thioredoxin on injury,
for example in the case of neuronal cells induced by ischemia/
reperfusion [45]. Thioredoxin may therefore be a promising
candidate for therapeutics to improve the prognosis and de-
velopment of FIC as well as of its human counterpart, IC.
To understand the relationship between fibronectin and its
potential interacting proteins, we performed immunohistochemi-
cal double labelling to determine the expression patterns of
fibronectin in association with thioredoxin. We could demonstrate
a colocalization of fibronectin and thioredoxin in the subepithelial
and muscular tunices of the healthy bladder (Fig. 5A), whereas
colocalization disappeared in FIC tissues (Fig. 5B). Interestingly,
a previous study investigating the effect of thioredoxin reductase 1
(TrxR1) silencing on gene expression in HepG2 cells identified
a regulation of fibronectin 1 gene [46]. However, to which extent
the interaction of fibronectin and thioredoxin takes place is still
unclear.
Regarding biological functions of thioredoxin, a further impor-
tant role is the redox regulation of transcription factors such as
NF-kB [41]. Immunohistochemical localization experiments of
NF-kB in bladder biopsies from patients with IC showed
a predominant activation in bladder urothelial cells and cells of
the submucosal layer in biopsies from patients with IC compared
to a diffuse and faint staining in control samples [47]. These
findings are consistent with our colocalization results of thior-
edoxin and NF-kB in bladder tissue of healthy (Fig. 5C) and FIC
cases (Fig. 5D). In addition, we found a significantly higher
concentration of NF-kB in urine of FIC cases (Fig. 1E). Research
on NF-kB-dependent processes in the pathogenesis of IC revealed
an interesting NF-kB-regulated increase of proinflammatory
cytokine gene products in the urine of IC patients in comparison
to controls suggesting a perpetuation of NF-kB activation via
a positive regulatory loop [48]. We could demonstrate an
interaction of thioredoxin and NF-kB in FIC tissues which is
supposed to play a crucial role in the pathogenesis of this disease.
NF-kB activation could reinforce proinflammatory cytokine
expression in the development of FIC. In turn, NF-kB-regulated
circulation of proinflammatory factors in combination with an
increased concentration of thioredoxin could therefore reinforce
NF-kB stimulation. This pathway could pose a vicious circle in the
Figure 5. Immunohistochemical double labelling of candidates in healthy (left panels) and diseased bladder tissue (right panels).
Immunohistochemical double staining of a healthy urinary bladder (A) shows considerable colocalization of fibronectin (green) and its interactor
thioredoxin (red) in the subepithelial and muscular tunices. In contrast, lack of green and red colour is evident in FIC (B), indicating a loss of both
fibronectin and thioredoxin from its normal distribution in healthy bladder tissue. Overlay image of thioredoxin (red) and NF-kB p65 (green) in
a healthy bladder tissue (C) shows a predominant signal of thioredoxin in all tunices of the bladder, whereas NF-kB p65 is not detectable in any tunic
of the healthy bladder. In contrast, thioredoxin and NF-kB p65 colocalize (overlapping results in yellow colour) in the lamina propria mucosae with
the highest expression in the extracellular matrix of FIC diseased bladder tissue (D). P38 MAPK signal is of moderate intensity localized in transitional
epithelium cells and around few blood vessels in the healthy bladder tissue (E). Note that the signal is exclusively of yellow colour indicating
a colocalization with thioredoxin, whereas a green colour signal is not visible at all. In contrast, p38 MAPK (green) was highly expressed in the
cytoplasm of umbrella cells of the transitional cell epithelium as well as a scattered expression around cell nuclei in the subepithelial and muscular
tunices of FIC diseased bladder sections without distinct colocalization (F). The blue colour reveals staining of cell nuclei (DAPI). a = Transitional cell
epithelium, b= Lamina propria mucosae, c =Muscle tunic.
doi:10.1371/journal.pone.0051391.g005
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pathogenesis of the disease and could lead to a chronic in-
flammatory response underlying the relapsing nature of FIC.
Another signal transduction pathway we were interested in is
the p38 MAPK pathway. Previous studies identified thioredoxin as
a negative regulator of the p38 MAPK pathway, which plays a role
in apoptosis regulation [21,49]. Moreover, p38 MAPK is well
known to be upregulated in urinary bladder cancer cells playing
a crucial role in tumour growth and progression [50]. In our study,
comparison of the concentration of urinary p38 MAPK in healthy
and FIC diseased specimens revealed a 6.5-fold higher concen-
tration in diseased urine (Fig. 1F). Furthermore, we could
demonstrate that in contrast to the low expression of p38 MAPK
in healthy tissues in transitional epithelium and subepithelial
tunices (Fig. 5E), p38 MAPK showed considerably higher
expression in FIC tissues (Fig. 5F). Interestingly, immunohisto-
chemical double staining of thioredoxin and p38 MAPK revealed
almost no colocalization in FIC affected bladder tissues. This could
be resulting from an inhibitory effect of thioredoxin expression on
p38 MAPK under FIC conditions interfering with cytokine- and
stress-induced apoptosis. However, loss of thioredoxin into the
urine could exhibit a negative factor in the progression of the
disease.
In conclusion, we identified different co-purified proteins of
fibronectin that are present in urine and urinary bladder tissue of
healthy controls and FIC cases. We could demonstrate a significant
alteration in diseased conditions compared to healthy controls
indicating an important role of these possible interacting partners
in the pathomechanism of the disease. As FIC serves as
spontaneous animal model for human IC, our findings could also
provide an interesting insight into the pathogenesis of IC.
Additionally, our study revealed an altered regulation of signal
transduction pathways such as NF-kB and p38 MAPK in FIC.
These pathways should be of major interest for future studies and
might provide the basis for a novel approach in FIC therapy.
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